121
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Human Lipocalin-1 Association with 3H-Testosterone and 3H-Estradiol

, &
Pages 1042-1049 | Received 11 Jun 2009, Accepted 07 Sep 2009, Published online: 03 Dec 2009

REFERENCES

  • Janssen PT, van Bijsterveld OP. Origin and biosynthesis of human tear fluid proteins. Invest Ophthalmol Vis Sci. 1983;24:623–630.
  • Glasgow BJ, Abduragimov AR, Farahbakhsh ZT, et al. Tear lipocalins bind a broad array of lipid ligands. Curr Eye Res. 1995;14:363–372.
  • Gasymov OK, Abduragimov AR, Glasgow BJ. Ligand binding site of tear lipocalin: Contribution of a trigonal cluster of charged residues probed by 8-anilino-1-naphthalenesulfonic acid. Biochemistry. 2008;47:1414–1424.
  • Flower DR. The lipocalin protein family: Structure and function. Biochem J. 1996;318:1–14.
  • Redl B, Holzfeind P, Lottspeich F. cDNA cloning and sequencing reveals human tear prealbumin to be a member of the lipophilic-ligand carrier protein superfamily. J Biol Chem. 1992;267:20282–20287.
  • åkerstrom B, Flower DR, Salier J-P. Lipocalins: Unity in diversity. Biochim Biophys Acta. 2000;1482:1–8.
  • Gasymov OK, Abduragimov AR, Prasher P, et al. Tear lipocalin: Evidence for a scavenging function to remove lipids from the human corneal surface. Invest Ophthalmol Vis Sci. 2005;46:3589–3596.
  • Gachon A-MF, Lacazette E. Tear lipocalin and the eye’s front line of defence. Br J Ophthalmol. 1998;82:453–455.
  • Fluckinger M, Haas H, Merschak P, et al. Human tear lipocalin exhibits antimicrobial activity by scavenging microbial siderophores. Antimicrob Agents Chemother. 2004;48:3367–3372.
  • Janssen PT, van Bijsterveld OP. The relations between tear fluid concentrations of lysozyme, tear-specific prealbumin and lactoferrin. Exp Eye Res. 1983;36:773–779.
  • Lemp MA. Report of National Eye Institute/industry workshop on clinical trials in dry eyes. CLAO J. 1995;21:221–232.
  • The definition and classification of dry eye disease: Report of the definition and classification subcommittee of The internation dry eye workshop (2007). Ocul Surf. 2007;5:75–92.
  • Sall K, Stevenson OD, Mundorf TK, et al. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. Ophthalmology. 2000;107:631–639.
  • Pflugfelder SC. Antiinflammatory therapy for dry eye. Am J Ophthalmol. 2004;137:337–342.
  • Sator MO, Joura EA, Golaszewski T, et al. Treatment of menopausal keratoconjunctivitis sicca with topical oestradiol. Brit J Obstet Gynaec. 1998;105:100–102.
  • Worda C, Nepp J, Huber JC, et al. Treatment of keratoconjunctivitis sicca with topical androgen. Maturitas. 2001;37:209–212.
  • Sullivan DA. Androgen deficiency and dry eye syndromes. Arch Soc Esp Oftalmol. 2004;79:49–50.
  • Versura P, Campos EC. Menopause and dry eye. A possible relationship. Gynecol Endocrinol. 2005;20:289–298.
  • Sullivan DA, Sullivan BD, Ullman MD, et al. Androgen influence on the meibomian gland. Invest Ophthalmol Vis Sci. 2000;41:3732–3742.
  • Rocha EM, Wickham LA, da Silveira LA, et al. Identification of androgen receptor protein and 5a-reductase mRNA in human ocular tissues. Br J Ophthalmol. 2000;84:76–84.
  • Tachibana M, Kasukabe T, Kobayashi Y, et al. Expression of estrogen receptor a and b in the mouse cornea. Invest Ophthalmol Vis Sci. 2000;41:668–670.
  • Tachibana M, Kobayashi Y, Kasukabe T, et al. Expression of androgen receptor in mouse eye tissues. Invest Ophthalmol Vis Sci. 2000;41:64–66.
  • Wickham LA, Gao J, Toda I, et al. Identification of androgen, estrogen and progesterone receptor mRNAs in the eye. Acta Ophthalmol Scand. 2000;78:146–153.
  • Suzuki T, Kinoshita Y, Tachibana M, et al. Expression of sex steroid hormone receptors in human cornea. Curr Eye Res. 2001;22:28–33.
  • Spelsberg H, Klueppel M, Reinhard T, et al. Detection of oestrogen receptors (ER) a and b in conjunctiva, lacrimal gland, and tarsal plates. Eye. 2004;18:729–733.
  • Wray W, Boulikas T, Wray VP, et al. Silver staining of proteins in polyacrylamide gels. Anal Biochem. 1981;118:197–203.
  • Molloy MP, Bolis S, Herbert BR, et al. Establishment of the human reflex tear two-dimensional polyacrylamide gel electrophoresis reference map: New proteins of potential diagnostic value. Electrophoresis. 1997;18:2811–2815.
  • Gasymov OK, Abduragimov AR, Yusifov TN, et al. Binding studies of tear lipocalin: The role of the conserved tryptophan in maintaining structure, stability and ligand affinity. Biochim Biophys Acta. 1999;1433:307–320.
  • Gasymov OK, Abduragimov AR, Glasgow BJ. Evidence for internal and external binding sites on human tear lipocalin. Arch Biochem Biophys. 2007;468:15–21.
  • Gouveia SM, Tiffany JM. Human tear viscosity: An interactive role for proteins and lipids. Biochim Biophys Acta. 2005;1753:155–163.
  • Ubels JL, Rismondo V, Osgood TB. The relationship between secretion of retinol and protein by the lacrimal gland. Invest Ophthalmol Vis Sci. 1989;30:952–960.
  • Glasgow BJ, Marshall G, Gasymov OK, et al. Tear lipocalins: Potential lipid scavengers for the corneal surface. Invest Ophthalmol Vis Sci. 1999;40:3100–3107.
  • Nagyová B, Tiffany JM. Components responsible for the surface tension of human tears. Curr Eye Res. 1999;19:4–11.
  • Mudgil P, Millar TJ. Adsorption of apo- and holo-tear lipocalin to a bovine Meibomian lipid film. Exp Eye Res. 2008;86:622–628.
  • Schlehuber S, Skerra A. Lipocalins in drug discovery: From natural ligand-binding proteins to ‘anticalins’. Drug Discov Today. 2005;10:23–33.
  • Schirra F, Suzuki T, Richards SM, et al. Androgen control of gene expression in the mouse meibomian gland. Invest Ophthalmol Vis Sci. 2005;46:3666–3675.
  • Lechner M, Wojnar P, Redl B. Human tear lipocalin acts as an oxidative-stress-induced scavenger of potentially harmful lipid peroxidation products in a cell culture system. Biochem J. 2001;356:129–135.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.